Radius

Radius is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of osteoporosis, cancer, and endocrine diseases.

Business Model:

Revenue: $223.4M

Employees: 201-500

Detailed Radius Information

Geographic Data

Radius headquarters map

Address: 22 Boston Wharf Road

City: Waltham

State: MA

Zip: 02210

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$175M

Raised Total:

$250M

Metrics

2,263,146Website Global Rank

8,420Website Monthly Traffic

Twitter Followers

Description

Radius is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of osteoporosis, cancer, and endocrine diseases.

Contact Phone:
+16175514000

Contact Email:

Radius went public on 6/9/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/9/2014

Ticker Symbol:
RDUS

Amount Raised:
$52M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2013 Private Equity Round 5 $43M Brookside Capital
MPM Capital
Biotech Growth
MPM Bio IV NVS Strategic Fund
BB Biotech Ventures
Brookside Capital
MPM Capital
Biotech Growth
MPM Bio IV NVS Strategic Fund
BB Biotech Ventures
12/2011 Private Equity Round 7 $21.4M Saints Capital
Brookside Capital
Scottish Widows Investment Partnership
HealthCare Ventures
Wellcome Trust
MPM Capital
BB Biotech Ventures
Saints Capital
Brookside Capital
Scottish Widows Investment Partnership
HealthCare Ventures
4/2007 Series B 6 $57.5M MPM Capital
Wellcome Trust
Scottish Widows Investment Partnership
Oxford Bioscience Partners
HealthCare Ventures
BB Biotech Ventures
MPM Capital
Wellcome Trust
9/2007 Series C 1 $10M MPM Bio IV NVS Strategic Fund
MPM Bio IV NVS Strategic Fund
11/2008 Series C 7 $15M MPM Bio IV NVS Strategic Fund
Scottish Widows Investment Partnership
Wellcome Trust
Oxford Bioscience Partners
MPM Capital
HealthCare Ventures
BB Biotech Ventures
MPM Bio IV NVS Strategic Fund
7/2011 Series C 9 $66M BB Biotech Ventures
MPM Capital
Scottish Widows Investment Partnership
Brookside Capital
HealthCare Ventures
Ipsen Pharma SA
Nordic Bioscience
Saints Capital
Wellcome Trust
BB Biotech Ventures
MPM Capital
7/2015 Post-IPO Equity $345M
6/2014 Venture Round 1 - Saints Capital
Saints Capital
6/2014 IPO $52M
11/2011 Unattributed $27.7M
8/2017 Post-IPO Debt $300M
3/2021 Post-IPO Debt $175M
2/2012 Series C $21.4M Brookside Capital
Saints capital
MPM Capital
BB Biotech Ventures
Wellcome Trust
Healthcare Ventures
6/2014 Venture Round 1 - Saints Capital
Saints Capital
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research